Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Heart arrest; This is a spontaneous report from a contactable other Healthcare Professional downloaded from the Regulatory Authority-WEB, Regulatory Authority number ES-AEMPS-738908. A 93-year-old male patient received the second dose of bnt162b2 (COMIRNATY), batch/lot number: EM0477, intramuscularly on 28Jan2021 at 0.3 mL, single for covid-19 immunization. Medical history included Chronic kidney disease, Chronic liver disease, Living in nursing home, cognitive impairment, epilepsy, hypertension, and dyslipidaemia. Concomitant medications included omeprazole 20 mg/12H, zopiclone 7.5 mg / night, iron succinyl-protein complex (FEROPLEX) 800mg / day, trazodone 100mg / night, clomethiazole (DISTRANEURINE) 2 / day, clopidogrel 75mg / day, levetiracetam 500mg / 8 hour. The patient previously received the first dose of bnt162b2 intramuscularly on 07Jan2021 at 0.3 mL, single for covid-19 immunisation. The patient experienced heart arrest on 30Jan2021 and died on 30Jan2021. They notify the Emergency Coordinating Center for sudden death. Death was certified. An autopsy was not performed. The outcome of heart arrest was fatal. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: heart arrest
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166